Having your Vision Therapy (Orthoptic Treatment) denied by insurance is frustrating, but you have legal rights and a strong path to overturn the denial. Approximately 40-60% of insurance denials are overturned on appeal when patients submit comprehensive documentation and cite applicable laws. This guide walks you through exactly why vision therapy claims get denied, what medical necessity criteria major insurers apply, and how to build the strongest possible appeal.
Important Disclaimer
This guide is for informational purposes only and does not constitute legal or medical advice. Insurance coverage rules vary by plan type, state, and individual circumstances. Consult with a patient advocate, healthcare attorney, or your state Department of Insurance for advice specific to your situation. Information current as of 2026-03-28.
Why Vision Therapy Gets Denied by Insurance
Vision Therapy denials typically fall into specific, predictable patterns. Understanding the exact reason for your denial is the first step to building an effective appeal. The most common denial reasons for Vision Therapy (Orthoptic Treatment) include:
- Reason 1: Insurer classifies vision therapy as experimental or investigational
- Reason 2: Plan excludes vision therapy or limits it to specific diagnoses
- Reason 3: Coverage falls between medical and vision insurance with neither accepting the claim
- Reason 4: The diagnosis (convergence insufficiency, amblyopia) is not recognized by the insurer's medical policy
- Reason 5: Provider is not credentialed as a vision therapy specialist by the insurer
Your Explanation of Benefits (EOB) or denial letter should include a specific reason code. Match that code to the reasons above to target your appeal effectively. If the denial letter is vague, you have the legal right to request the specific clinical criteria used to evaluate your claim.
Common Denial Codes for Vision Therapy
Insurance companies use standardized codes to explain denials. Here are the codes most frequently associated with vision therapy denials:
| Denial Code | What It Means |
|---|---|
| CO-27 | Expenses for experimental/investigational service |
| CO-96 | Non-covered charge |
| CO-50 | Not medically necessary |
| CO-167 | Diagnosis not covered |
Understanding your specific denial code helps you tailor your appeal to address the exact basis for denial rather than making generic arguments. Request your complete claims file if the denial codes are not clear from your EOB. Use our EOB Decoder tool to understand your denial documentation.
Medical Necessity Criteria for Vision Therapy
Vision therapy is evidence-based for specific conditions, particularly convergence insufficiency in children (supported by the CITT randomized controlled trial). However, many insurers still classify it as experimental or investigational. Medical insurance typically covers vision therapy when it treats a medical condition (strabismus, traumatic brain injury-related vision problems, post-concussion oculomotor dysfunction). Vision insurance may cover therapy sessions but often with limited visit counts. The American Academy of Ophthalmology and American Optometric Association differ in their positions, which insurers sometimes exploit for denial. Key evidence includes the Convergence Insufficiency Treatment Trial (CITT) and studies on post-concussion vision rehabilitation.
Key Takeaway
Each insurer applies different medical necessity criteria for vision therapy. Request your specific insurer's medical policy for this procedure. The criteria they use must be disclosed to you upon request, and your appeal should address each criterion point by point.
Step-by-Step Appeal Process for Vision Therapy
Step 1: Request the Complete Written Denial
Contact your insurer and request the full written denial including the specific clinical criteria used, the reviewer's credentials, and your appeal rights and deadlines. Under ACA Section 2719, you are entitled to this information. Keep a log of every communication with your insurer — dates, names, reference numbers.
Step 2: Obtain Your Complete Medical Records
Request all records relevant to your vision therapy claim from every provider involved. Under HIPAA, you are entitled to your complete medical records. Focus on documentation that directly addresses the denial reason.
Step 3: Get a Letter of Medical Necessity from Your Provider
Ask your treating physician to write a detailed letter explaining exactly why Vision Therapy (Orthoptic Treatment) is medically necessary for your specific condition. The letter should reference the insurer's specific medical policy criteria and address each requirement. A generic letter is far less effective than one that directly responds to the denial reason.
Step 4: Gather Supporting Clinical Evidence
Collect clinical practice guidelines from relevant medical societies, peer-reviewed research supporting the procedure for your diagnosis, and any applicable insurer-specific policy bulletins. Evidence from the same clinical guidelines the insurer references is particularly powerful.
Step 5: Write and Submit Your Appeal
Your appeal should cite specific laws (ACA Section 2719, ERISA Section 503 if applicable, and relevant state laws), address the exact denial reason with point-by-point rebuttal, include all supporting documentation, and request a specific outcome (approval of the denied service). Submit by certified mail or through the insurer's online portal with delivery confirmation.
Step 6: If Denied, Escalate to External Review
If your internal appeal is denied, you have the right to an external review by an Independent Review Organization (IRO) under the ACA. The external reviewer is independent of the insurer and makes a binding determination. External review must be requested within 4 months of the internal appeal denial in most states. For urgent situations, expedited external review must be decided within 72 hours.
Sample Appeal Letter Language for Vision Therapy
Sample Appeal Excerpt
I appeal the denial of vision therapy, claim [X], denied as [experimental/not medically necessary]. The patient has [specific diagnosis: convergence insufficiency/strabismus/post-concussion oculomotor dysfunction] documented by [comprehensive eye examination on date]. The Convergence Insufficiency Treatment Trial (CITT), published in Archives of Ophthalmology, demonstrated that office-based vision therapy is significantly more effective than home-based exercises or placebo for convergence insufficiency. The American Optometric Association recognizes vision therapy as evidence-based treatment. This is not experimental — it is supported by Level I randomized controlled trial evidence.
Customize this language with your specific details — claim numbers, dates, provider names, and clinical findings. A personalized appeal that addresses the specific denial reason is significantly more effective than a generic template. Use our free appeal letter generator to build a complete letter.
Supporting Documentation to Strengthen Your Appeal
For vision therapy appeals, gather the following documentation before submitting:
- Comprehensive eye examination results with specific diagnosis
- Objective measurements (near point of convergence, vergence ranges, accommodative facility)
- Optometrist or ophthalmologist letter of medical necessity
- CITT study citation and relevance to the patient's condition
- Documentation of functional impairment (reading difficulties, headaches, academic impact)
- Treatment plan with specific measurable goals and estimated duration
Organize your documentation clearly with a cover page listing all enclosed items. Number each exhibit and reference them specifically in your appeal letter. Incomplete or disorganized submissions are easier for insurers to deny.
Success Rate and Tips for Vision Therapy Appeals
While specific success rates vary by insurer and clinical scenario, data from state insurance regulators suggests that 40-60% of medical necessity denials are overturned when patients pursue a comprehensive appeal. For vision therapy specifically, the following strategies may improve your chances:
- Cite the CITT randomized controlled trial as Level I evidence for convergence insufficiency
- Frame the claim under medical insurance if the condition results from trauma or medical diagnosis
- Include objective measurements (near point of convergence, vergence ranges) to quantify the deficit
- For children, document academic impact to strengthen the case for medical necessity
The single most important factor in appeal success is the quality and specificity of your documentation. Generic appeals fail. Appeals that address the exact denial reason with targeted clinical evidence succeed at much higher rates.
Check your appeal deadline to ensure you file within the required timeframe. Missing the deadline may forfeit your appeal rights entirely.
Frequently Asked Questions
Is vision therapy covered by medical insurance?
Medical insurance may cover vision therapy when it treats a medical condition such as strabismus, traumatic brain injury-related vision problems, or post-concussion oculomotor dysfunction. Coverage is more likely when the therapy is prescribed by a physician and the diagnosis is a recognized medical condition. If your medical insurance denies, check whether your vision insurance plan covers therapy sessions. The billing codes used (medical vs. vision) can significantly affect coverage.
Is vision therapy experimental?
No. Vision therapy for convergence insufficiency is supported by the Convergence Insufficiency Treatment Trial (CITT), a National Eye Institute-funded, multicenter randomized controlled trial published in a peer-reviewed ophthalmology journal. This constitutes Level I evidence, the highest level of clinical evidence. For other conditions such as strabismus and post-concussion vision problems, multiple peer-reviewed studies support efficacy. If your insurer classifies vision therapy as experimental, appeal with these specific citations.
Does vision therapy help children with reading difficulties?
Vision therapy may help children whose reading difficulties stem from a diagnosable vision condition such as convergence insufficiency, accommodative dysfunction, or oculomotor dysfunction. A comprehensive binocular vision evaluation can determine whether a treatable vision condition is contributing to reading problems. Vision therapy is not a treatment for dyslexia or learning disabilities, but undiagnosed vision conditions can coexist with and exacerbate these conditions.
How many vision therapy sessions does insurance cover?
When covered, insurers typically authorize 12-24 sessions initially, with re-authorization possible based on documented progress. Most vision therapy treatment plans span 12-36 sessions depending on the condition and severity. Your provider should document objective measurements at baseline and at regular intervals to demonstrate progress and justify continued sessions. Re-authorization requests should include updated measurements and remaining treatment goals.
Should I file vision therapy under medical or vision insurance?
File under medical insurance if the vision therapy treats a medical condition (traumatic brain injury, strabismus, post-surgical rehabilitation). File under vision insurance if the plan specifically covers vision therapy services. Some patients have success filing under both — medical for the diagnosis and evaluation, vision for the therapy sessions. Check both plans' coverage provisions and work with your provider's billing office to determine the optimal filing strategy.
Sources: ACA Section 2719 · ERISA Section 503 · No Surprises Act · CMS regulations · State insurance codes · Clinical practice guidelines. Disclaimer: This article is for informational purposes only. Coverage rules vary by plan type and state. Consult a patient advocate or healthcare attorney for advice specific to your situation. Last updated: 2026-03-28.